Results 201 to 210 of about 116,711 (254)
Management of traumatic degloving injury of the dorsal aspect of the midfoot and ankle: A case report. [PDF]
Mourafiq O+3 more
europepmc +1 more source
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray+2 more
wiley +1 more source
Evaluating the Effectiveness of Targeted Interventions on the Quality of Life for Patients with Ischemic Stroke. [PDF]
Al Harbi S+10 more
europepmc +1 more source
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi+4 more
wiley +1 more source
Healthcare Models and Quality Indicators in the Management of Patients with Heart Failure in Spain: Results from the CARABELA-HF Initiative. [PDF]
Mediavilla I+5 more
europepmc +1 more source
Interventional therapies for chronic heart failure: An overview of recent developments
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo+7 more
wiley +1 more source
Where Do We Stand in the Management of Rheumatoid Arthritis Ahead of EULAR/ACR 2025? [PDF]
Vlad AL+4 more
europepmc +1 more source
Abstract Aims Information about current use of finerenone in patients with heart failure (HF) finerenone in clinical practice is scarce, and its effectiveness in clinical practice in patients is scarce. We aim to assess both the baseline clinical profile and prognostic role of finerenone in patients with HF, irrespective of ejection fraction.
Gonzalo Luis Alonso Salinas+32 more
wiley +1 more source